White House vaccine diplomacy addresses the barriers that apply
Managers still have to send any promised 80 million vaccines abroad as they face challenges in many sectors.White House commitment to export millions of Covid-19 vaccine overseas has created negotiating and operational challenges for regulatory authorities to address as many countries seek US assistance to overcome shortages of vaccines.
Since President Joe Biden announced this month that 80 million guns would be exported by the end of June, the White House has yet to send any volumes due to various issues ranging from planning to control. At present, infections are on the rise in countries from Haiti to Japan, fighting organizational challenges and having only a fraction of the doses they need.
With the need for a shotgun and half of the adults completely vaccinated, the U.S. It has an excessive provision for using vaccination conversations. About 70 million doses of Pfizer, Moderna and Johnson & Johnson vaccines are yet to be prescribed, according to data from the Centers for Disease Control and Prevention. But deciding where to go and take them to where they are needed is a herculean task, says a person familiar with the process.
The provincial government has been sending out volumes as soon as they leave production plants at tens of thousands of commercial pharmacies, vaccination centers and public health clinics across the country. That means there is no central location where millions of volumes can be stored and can be easily packed and loaded onto planes.
White House Covid-19 coordinator Andy Slavitt said Wednesday that the U.S. It is trying to move to a “strong distribution system” so that the provincial government can keep a better track of prices and export.
Read it : WHITE HOUSE VACCINE DIPLOMACY ADDRESSES
There is also the challenge of transporting tens of millions of volumes worldwide, ensuring adequate flights and ensuring that the volumes are properly stored and that the countries they receive have the infrastructure to refrigerate and distribute them, said the administration official. .
The official said management should have a review in the coming days where some of the doses are targeted.
Another major potential problem is obtaining authorization for food and drug administration with the AstraZeneca vaccine. Of the 80 million doses promised so far, 60 million should have come from AstraZeneca – but authorities say they will not release those doses until the drug is cleared by U.S. regulators, even if it is approved for use in other countries.
THE U.S. TELLS RUSSIA IT WILL NEVER AGAIN MEET THE ARMS CONTROL TREATY ‘RUINED BY RUSSIA’S VIOLATIONS’
The FDA review process has been delayed by detailed problems with AstraZeneca research, and it is unclear when the AstraZeneca vaccine will be available – or even if.
Then there is the diminished balance in trying to figure out which countries should get the rating and how many key allies are fighting the deficit. It is a problem Biden could face when he meets world leaders next month at the G7 summit in the UK, his first major international event
When Biden said the U.S. It will not use doses for international protection, but acknowledged that this action is an important tool in combating China and Russia’s efforts to gain influence over their vaccines.
“There is a lot of talk about Russia and China that have an impact on the world with vaccines. We want to lead the world with our values, this shows our wisdom, ingenuity and basic morals of the American people,” Biden announced the move this month. “Just as in World War II the United States was a democracy, in the fight against the Covid-19 epidemic our country will become a global vaccine.”
Following a recent meeting with the president of South Korea, in which about 3 percent of the population was completely vaccinated, Biden said the U.S. It will provide 500,000 doses of vaccine to members of the U.S. military and military service in the country.
Officials say little about its policy of determining which countries receive the ratings and how many, without the broad goal of sending them where many lives could be saved.
“Those decisions are based on two things: science and public health, and equality – not other things,” Slavitt said.
One of the countries most in need is Haiti: Vaccines have never been vaccinated, and while there are no definite statistics on how many people are infected, public health officials say the number of cases is increasing.
The Haitian government has announced that it will accept 130,000 doses of AstraZeneca vaccine from the international aid group COVAX, a country that had previously rejected it; doses could arrive in June, according to the Pan American Health Organization.
But that is just the tip of the iceberg for the 11 million people in the world. Public health workers say a single Johnson & Johnson vaccine will make a big difference to Haiti, where recruiting people to get two AstraZeneca rifles could be a challenge.
Biden has given Jeffrey Zients, White House accounting coordinator, to lead these efforts. He also works with national security adviser Jake Sullivan and Gayle Smith, the Covid-19 global response coordinator for the Department of State. Staff members in the U.S. The Agency for International Development and the Department of Health and Human Services are also involved.
The White House said it was working with the World Health Organization and COVAX, which works to obtain vaccines in low- and middle-income countries, to ensure that doses are evenly distributed.
The administrative officer acknowledged the challenges of the release, saying the commitment could be just the beginning.